Picture of Ziccum AB logo

ZICC Ziccum AB Share Price

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Momentum

Relative Strength (%)
1m+0.2%
3m-19.61%
6m+1.22%
1yr+25.7%
Volume Change (%)
10d/3m-48.98%
Price vs... (%)
52w High-35.35%
50d MA-2.26%
200d MA-7.55%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-243.07%
Return on Equity-113.04%
Operating Margin-575.39%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Ziccum AB EPS forecast chart

Profile Summary

Ziccum AB is a Sweden-based pharmaceutical company that is mainly engaged in developing vaccines. Ziccum develops new thermostable versions of vaccines and biologics for licensing to vaccine suppliers, developers, manufacturers and CDMOs in the global pharmaceutical industry. Ziccum's patented drying technology, LaminarPace, is unique. It can dry-formulate temperature-sensitive vaccine materials at room temperature with high yield and low waste. These robust, thermostable dry powders can be stored and transported worldwide without the need for a cold chain or freezing. The company conducts its business by entering into strategic collaborations with major pharmaceutical companies and offering licenses to the Company's patented technology.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    May 31st, 2018
    Public Since
    October 25th, 2018
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    se flag iconOMX Nordic Exchange Stockholm
    Shares in Issue
    15,340,157

    ZICC Share Price Performance

    Upcoming Events for ZICC

    Q1 2024 Ziccum AB Earnings Release

    Ziccum AB Annual Shareholders Meeting

    Q2 2024 Ziccum AB Earnings Release

    Similar to ZICC

    Picture of Biogaia AB logo

    Biogaia AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of BoneSupport Holding AB logo

    BoneSupport Holding AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Calliditas Therapeutics AB logo

    Calliditas Therapeutics AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Camurus AB logo

    Camurus AB

    se flag iconOMX Nordic Exchange Stockholm

    Picture of Cline Scientific AB logo

    Cline Scientific AB

    se flag iconOMX Nordic Exchange Stockholm

    FAQ